DA-3003-2 – 25 mg

Brand:
Cayman
CAS:
383907-47-9
Storage:
-20
UN-No:
Non-Hazardous - /

Cdc25 dual-specific protein tyrosine phosphatases are important for cell cycle progression and often overexpressed in cancers. Through the removal of inhibitory phosphates, they function to catalyze the activation of cyclin-Cdk complexes. DA-3003-2 is a Cdc25 phosphatase inhibitor (IC50 = 0.82 µM for human recombinant Cdc25B) that demonstrates antiproliferative activity.{17980,28275,28276} At 20 µM, it has been shown to arrest asynchronous PC-3 prostate cancer cells in G2/M phase.{28276}  

 

Available on backorder

SKU: - Category:

Description

A Cdc25 phosphatase inhibitor (IC50 = 0.82 µM for human recombinant Cdc25B); arrests asynchronous PC-3 prostate cancer cells in G2/M phase at 20 µM


Formal name: 7-chloro-6-[[2-(4-morpholinyl)ethyl]amino]-5,8-quinolinedione

Synonyms:  NSC 663285

Molecular weight: 321.8

CAS: 383907-47-9

Purity: ≥98%

Formulation: A crystalline solid


Product Type|Biochemicals|Small Molecule Inhibitors|Phosphatases||Research Area|Cancer|Cell Cycle|G2/M||Research Area|Cancer|Cell Signaling